Obesity and cardiovascular diseases - Theoretical background and therapeutic consequences;Adipositas und Herz-und Kreislauferkrankungen - Grundlagen und therapeutische Konsequenzen

Zeitschrift fur Kardiologie

Volumn 93, Issue 7, 2004, Pages 503-513

  Voller H ^a   Schmailzl, K J G ^b   Bjarnason Wehrens, B ^c  

^a Klinik am See   (Germany)

^b Ruppiner Kliniken GmbH   (Germany)

^c GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Cardiovascular risk factors; Medical genetics; Nutrition; Obesity; Physical activity

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; LEPTIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

BLOOD VOLUME; BODY FAT; BODY MASS; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; ENERGY CONSUMPTION; ENERGY METABOLISM; ENZYME ACTIVITY; FEEDBACK SYSTEM; FOOD COMPOSITION; GENE MUTATION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; INCREASED APPETITE; INSOMNIA; INSULIN SENSITIVITY; LIFESTYLE; LIPID METABOLISM; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIDE EFFECT; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE; THERMOGENESIS; XEROSTOMIA; ADOLESCENT; ADULT; BODY COMPOSITION; CHILD; EXERCISE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; INSULIN RESISTANCE; LOW CALORY DIET; PHYSIOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; DIET, REDUCING; EXERCISE; HEMODYNAMIC PROCESSES; HUMANS; INSULIN RESISTANCE; OBESITY; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 3242883330     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E (1999) Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 106:179-184
2. Assmann GH, Schulte H, Cullen P (1997) New and classical risk factors - The Münster Heart Study (PROCAM). Europ J Med Res 2:6
3. Ballor DL, Keesey RE (1991) A metaanalysis of the factors affecting exercise-induced changes in body mass, fat mass and fat free mass. Int J Obes 15:717-726
4. Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau J-L, Drury PL, Esmatjes E, Hricik D, Parikh CR, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber F, Lewis EJ, for the Collaborative Study Group (2003) Cardiovascular outcomes in the irbesartan diabetic nephropathy trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med 138:542-549
5. Blair SN, Brodney S (1999) Effects of physical inactivity and obesity on morbidity and mortality: current evidence and research issues. Med Sci Sports Exerc 31(11 Suppl):646-662
6. Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Theriault G, Dussault J, Moorjani S, Pinault S, Fournier G (1990) The response to long-term overfeeding in identical twins. N Eng J Med 322:1477-1482
7. Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB (1999) Sibutramine produces dose-related weight loss. Obes Res 7:189-198
8. Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving HH, Reuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869
9. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabet Care 17:961-967
10. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Undholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, for the LIFE study group (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995-1003
11. Davidson MH, Hauptmann J, DiGirolamo M (1999) Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. A randomized controlled trail. J Am Med Assoc 281:235-242
12. De Divitiis O, Fazio S, Petitto M, Maddalena G, Contaldo F, Mancini M (1981) Obesity and cardiac function. Circulation 64:477-482
13. De la Maza MP, Estevez A, Bunout D, Klenner C, Oyonarte M, Hirsch S (1994) Ventricular mass in hypertensive and normotensive obese subjects. Int J Obesity 18:193-197
14. DeFronso RA (1991) Ferraninnini: insulin resistance. A mutifaceted syndrome responsible for NIDDM, obesity, hypertension, dylipidemia, and atherosclerotic cardiovascular disease. Diabet Care 14:173-194
15. Deutsche Adipositas-Gesellschaft (1998) Leitlinien der Deutschen Adipositas-Gesellschaft zur Therapie der Adipositas. Adipositas 16:6-28
16. Deutsche Hochdruckliga/Deutsche Hypertonie Gesellschaft (2001) Leitlinien für Prävention, Erkennung, Diagnostik und Therapie der arteriellen Hypertonie. Dtsch Med Wochenschr 126:201-238
17. Devereux RB, Roman MJ, Liu JE, Welty TK, Lee ET, Rodeheffer R, Fabsitz R, Howard BV (2000) Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the strong heart study. Am J Cardiol 86:1090-1096
18. Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403
19. Epstein LH, Goldfield GS (1999) Physical activity in the treatment of childhood overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 31(Suppl 11):553-559
20. Executive summary of the clinical guidelines on the identification, evaluation, and measurement of overweight and obesity in adults (1998) Arch Intern Med 158:1855-1867
21. Fagard RH (1999) Physical activity in the prevention and treatment of hypertension in the obese. Med Sci Sports Exerc 31(Suppl 11):624-630
22. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults 1999-2000. JAMA 288:1723-1727
23. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults. JAMA 287: 356-359
24. Frayn KN, Williams CM, Arner P (1996) Are increased plasma non-esterified fatty acidconcentrations a risk marker for coronary heart disease and other chronis diseases? Clin Sci 90:243-253
25. Friedman JM (2000) Obesity in the new millenium. Nature 404:632-634
26. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393
27. Gortmaker SL, Must A, Sobol AM, Peterson K, Colditz CA, Dietz WH (1996) Television viewing as a causeon increasing obesity among children in the United States, 1986-1990. Arch Pediatr Adolesc Med 150:356-362
28. Grassi G, Cattaneo BM, Seravalle G, Colombo M, Cavagnini F, Mancia G (1996) Obesity and the sympathetic nervous system. Blood Press (Suppl)1:43-46
29. Guercolini R (1997) Mode of action of orlistat. Int J Obes Relat Metab Disord 21:512-523
30. Guidelines Subcommittee 1999 World Health Organization-International Society of Hypertension Guidelines for the management of Hypertension ISH (1999) Hypertension No.1
31. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234
32. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard JH, Rahn KH, Wedel H, Westerling S (1998) Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: prindpal results of the Hypertension Optimal Treatment (HOT) randomised trial. Hot Study Group, Lancet 351:1755-1762
33. Hersey WC III, Graves JE, Pollock ML, Gingerich R, Shireman RB, Heath GW, Spierto F, McCole SD, Hagberg JM (1994) Endurance exercise training improves body composition and plasma insulin responses in 70-79-year-old men and women. Metabolism 43:847-854
34. Heshka S, Anderson JW, Atkinson RL, Greenway FL, Hill JO, Phinney SD, Kolotkin RL, Miller-Kovach K, Pi-Sunyer FX (2003) Weight loss with self-help compared with a structured commercial program. JAMA 289:1792-1798
35. Hill JO, Hauptman J, Anderson JW, Fujioka K, O'Neil PM, Smith DK, Zavoral JH, Aronne LJ (1999) University of Colorado health sciences center, Denver, USA. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting - a 1 year study. Am J Clin Nutr 69(6):1108-1116
36. Howard, BV (1999) Obesity and lipoprotein metabolism: relationship to cardiovascular disease. In: Fletcher GF, Grundy SM, Hayman LL (eds) Obesity: Impact on cadriovascular disease. Armonk, New York, Chapter 9 of 155-167
37. Huang Z, Willett, WC, Manson JE, Rosner B, Stampfer MJ, Speizer FE, Colditz GA (1998) Body weight, weight change, and risk for hypertension in women. Ann Intern Med 128:81-88
38. Jakicic JM, Winters C, Lang W, Wing RR (1999) Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight women. JAMA 282:1554-1560
39. Kelley DE, Goodpaster BH (1999) Effects of physical activity on insulin and glucose tolerance in obesity. Med Sci Sports Exerc 31(Suppl 11):619-623
40. Kolterman OG, Insel J, Sackow M, Olefsky M (1980) Mechanismus of insulin resistance in human obesity. J Clin Invest 65:1272-1284
41. Kopelman PG (2000) Obesity as a medical problem. Nature 404:635-643
42. Landsberg L, Saville ME ,Young JB (1984) Sympathoadrenal system and regulation of thermogenesis. Am Physiol 247:E181-E189
43. Lauer MS, Anderson KM, Kannel WB, Levy D (1991) The impact of obesity on left ventricular mass and geometry. J Am Med Assoc 266:231-236
44. Lean MEJ, Han TS, Morrison CE (1995) Waist as a measure for indicating need for weight management. Brit Med J 311:158-160
45. Levine JA, Eberhardt NL, Jensen MD (1999) Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 283:212-214
46. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JA, Ritz E, Atkins RC, Rohde R, Raz I (2001) Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860
47. Licata G, Scaglione R, Barbagallo M, Parrinello G, Capuana G, Lipari R, Merlino G, Ganguzza A (1991) Effect of obesity on left ventricular function studied by radionuclide angiocardiography. Int J Obes 15:295-302
48. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S; LIFE Study Group (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:1004-1010
49. Liu JE, Palmieri V, Roman MJ, Bella JN, Fabsitz R, Howard BV, Welty, TK, Lee ET, Devereux RB (2001) The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the strong heart study. J Am Coll Cardiol 37:1943-1949
50. Lowell BB, Spiegelman BM (2000) Towards a molecular understanding of adaptive thermogenesis. Nature 404:652-660
51. Ludwig DS, Pereira MA, Kroenke, CH, Hilner, JE, Van Horn L, Slattery, ML, Jacobs DR (1999) Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 282:1539-1546
52. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature med 1:1155-1161
53. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG (1999) State-of-the-art-lecture: obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertension 33:537-541
54. Miller WC, Koceja DM, Hamilton EJ (1997) A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet with exercise intervention. Int J Obes 21:941-947
55. Mokdad AH, Ford ES, Bowman BA, Vinicor F, Marks JS, Koplan JP (2001) The continuing epidemics of obesity and diabetes in the United States JAMA 286:1195-1199
56. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76-79
57. Montague CT (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908
58. National Institutes of Health (NIH) and National Heart, Lung, and Blood Institute (NHLBI) (1998) Clinical guidelines on the indentification, evaluation and treatment of overweight an obesity in adults. Evidence based report, Bethesda MD:NIH NHLBI www.nhlbi.nih.gov
59. Nawaz H, Katz DL (2001) American college of preventive medicine practice policy statement. Weight management counseling of overweight adults. Am J Prev Med 21:73-78
60. NIH Consensus Development Conference Statement (1992) Gastrointestinal surgery for severe obesity. Am J Clin Nutr 55(Suppl):S615-619
61. Ogden CL, Flegal KM, Carroll MD, Johnson CL (2002) Prevalence and trends in overweight among US children and adolescents, 1999-2000 JAMA 288:1728-1732
62. Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR (2003) The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination. Survey, 1988-1994. Arch Intern Med 163:427-436
63. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux, L (2003) Obesity in adulhood and ist consequences for life expectancy: a life table analysis. Ann Intern Med 138:24-32
64. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269 (5223):475-476
65. Pereira MA, Jacobs DR Jr, Horn L van, Slattery ML, Kartashov AI, Ludwig DS (2002) Dairy consumption, obesity, and the insulin resistance syndrome in young adults. JAMA 287:2081-2089
66. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunktion in the community. JAMA 289:194-202
67. Romijn JA, Cycle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, Wolfe RR (1993) Regulation of endogenous fat and carbohydrate matabolism in relation to exercise intensity and duration. Am J Physiol 265:380-391
68. Ross R, Rissanen J (1994) Mobilization of visceral and subcutaneous adipose tissue in response to energy restriction and exercise. Am J Clin Nutr 60:695-703
69. Rowlands AV, Ingledew DK, Eston RG (2000) The effect of type of physical activity measure on the relationship between body fatness and habitual physical activity in children: a meta-analysis. Ann Hum Biol 27:479-497
70. Ryan D, Kaiser HP, Bray GA (1995) Sibutramine: a novel new agent for obesity treatment. Obesity Res 3: 553s-559s
71. Schwimmer JB, Burwinkle TM, Varni JW (2003) Health-related quality of life of severely obese children and adolescents. JAMA 289:1813-1819
72. Shibata H, Bukowiecki LJ (1987) Regulatory alterations of daily energy expenditure induced by fasting or overfeeding in unrestrained rats. J Appl Physiol 63:465-470
73. Sims EA, Danforth E Jr (1987) Expenditure and storage of energy in man. J Clin Invest 79:1019-1025
74. Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M (1998) Randomized placebo-controlled trail of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 352:167-172
75. Stefanick ML (1999) Physical activity for preventing and treating obesity-related dyslipoproteinemias. Med Sci Sports Exerc 31(Suppl 11):609-618
76. Tate DF, Jackvony EH, Wing RR (2003) Effects of internet behavioral counseling on weight loss in adults at risk for type 2 diabetes JAMA 289: 1833-1836
77. Thomas SA, Palmiter RD (1997) Thermoregulatory and metabolic phonotypes of mice lacking noradrenaline and adrenaline. Nature 387:94-97
78. Thompsen D, Edelsberg J, Colditz GA, Bird AP, Oster G (1999) Lifetime health and economic consequences of obesity. Ach Intern Med 159:2177-2183
79. Troiano RP, Frongillo EA Jr, Sobal J, Levitsky DA (1996) The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes Relat Metab Disord 20:63-75
80. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M (1981) The effect of weight reduction on blood pressure, plasma renin activity, and plasma adolsterone levels in obese patients. New Engl J Med 304:930-933
81. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M (2001) Finnish diabetes prevention study group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350
82. Tuomiletho J, Rastenyte D, Birkenhäger WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R (1999) Effects of calcium channel blockade in older patients with diabetes and systotic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med 340:677-684
83. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 317:703-713
84. Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC (1996) Body size and fat distribution as predictors of stroke among US men. Amer J Epidemiol 144:1143-1150
85. Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RS, Blair SN (1999) Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese man. JAMA 282:1547-1553
86. WHO Consultation on obesity G, 3-5 June (1997) Obesity - prevention and managing the global epidemic. WHO 1-276
87. WHO report obesity (1998) Preventing and managing the global epidemic. World Health Organization, Geneva
88. Wood PD, Stefanick ML, Williams PT, Haskell WL (1991) The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight. N Engl J Med 325:461-466
89. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedmann JM (1994) Positional cloning of the mouse obese gene and ist human homologue. Nature 372:425-432